The largest database of trusted experimental protocols

12 protocols using angiotensin 2

1

Cardiovascular Effects of Angiotensin II Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
A-779 (5-L-isoleucine-7-D-alanine-1-7-angiotensin II, trifluoroacetate salt); AM251 [(N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide)]; angiotensin 1–7; angiotensin II (Tocris Bioscience, Bristol, UK); betadine (Egis Pharmaceuticals PLC, Budapest, Hungary); buprenorphine (Richter Pharma AG, Wels, Austria); CP55940 [(−)-cis-3-[2-hydroxy4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol] (Sigma Aldrich, St. Louis, MO, USA); losartan potassium (Tocris Bioscience, Bristol, UK); paracetamol (Sequoia, Warsaw, Poland); PD123319 ((6S)-1-[[4-(dimethylamino)-3-methylphenyl]methyl]5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid, di(2,2,2-trifluoroacetate)) (Sigma Aldrich, St. Louis, MO, USA); pentobarbitone sodium (Biowet, Puławy, Poland).
Drugs were dissolved in saline with the following exceptions. AM251 was dissolved in a mixture of ethanol, Cremophor El, DMSO and saline (1:1:1:9.5) for i.v. injections and in DMSO and saline (1:9) for PVN injections. CP55940 was dissolved in a 19% solution of cyclodextrin. None of the used vehicles significantly altered any of the cardiovascular parameters by itself (data not shown).
+ Open protocol
+ Expand
2

Vasoreactive Drug Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
When appropriate, gastrodin (100 μmol/L, dissolved in PBS), RO2959 (Glixx Laboratories, Southborough, MA, USA, GLXC-01511) (5 μmol/L, dissolved in DMSO) were added 12 h before phenylephrine (Sigma-Aldrich, St. Louis, MO, USA, P6126) (50 μmol/L, dissolved in PBS), angiotensin II (Tocris, Bristol, UK, 1158) (10 nmol/L, dissolved in water) and endothelin-1 (Tocris, Bristol, UK,1160) (100 nmol/L, dissolved in water) application. The culture media containing different drugs were renewed every 24 h.
+ Open protocol
+ Expand
3

Investigating GLP-1 Receptor Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
GLP-1 (7-36), Exendin-4 (EX4; GLP-1R agonist), Exendin 9-39 (Ex9-39; GLP-1R antagonist), para-chlorophenylalanine (PCPA), R-96544 (selective 5HT2A antagonist (21 (link))), SB242084 (5HT2C antagonist (22 (link))), and angiotensin II were purchased from Tocris (Bristol, UK). All substances, except for SB242084, Liraglutide, and PCPA, were dissolved in artificial cerebrospinal fluid (aCSF), vehicle for central injections. Liraglutide (Bachem) was dissolved in 0.9% saline. PCPA was dissolved in 0.9% saline by gentle warming and sonication to a concentration of 100 mg/ml (23 (link), 24 (link)). SB242084 was dissolved in 16% DMSO. 5HT2C receptor antagonist SB242084 displays 158- and 100-fold selectivity over 5HT2A and 5HT2B receptors respectively and it also displays selectivity over a range of other 5-HT, dopamine and adrenergic receptors. R-96544 is a potent, selective 5HT2A receptor antagonist; R-96544 shows 100-fold higher affinity for the human 5HT2A receptors than 5HT1A, 5HT1B, 5HT1D, 5HT5A, 5HT6, 5HT7 receptors and 5-HT transporter, although R-96544 has relatively high affinity for 5HT2C receptors (fourfold less compared to 5-HT2A) (21 (link)).
+ Open protocol
+ Expand
4

I-S1 and T-Alb Biodistribution in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
In anesthetized mice, the left jugular vein was exposed for an iv injection of 0.1 mL BSA-LR containing 3×105 cpm of I-S1 (RayBiotech) and 6×105 cpm of T-Alb. For some mice, the injection contained 1 μg/mouse of unlabeled S1 (AMSBIO), mouse acyl ghrelin (CBio, Menlo Park, CA), angiotensin II (Tocris, Bristol, UK), or human ACE2 (R&D, Minneapolis, MN). Ten min after iv injection, whole blood was obtained from the carotid artery and centrifuged after clotting. The whole brain, olfactory bulb, kidney, spleen, and portions of the liver and lung removed. The levels of radioactivity in the arterial serum and the tissues were determined and the results expressed as the percent of the injected I-S1 per mL for serum and delta tissue/serum ratios (μL/g) for the tissues.
+ Open protocol
+ Expand
5

Intracerebroventricular Cannulation and MTII Administration in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-to 10-week-old male mice were stereotaxically implanted with a guide cannula (Plastics1, Roanoake, VA) into the right lateral ventricle (0.4 mm posterior, 1 mm lateral from bregma) under 1–3% (v/v) isoflurane in 1 L/min oxygen. Animals were allowed 6–7 days to recover before the ICV cannula placement was verified through administration of angiotensin II (Tocris, 20 ng in 2 uL) and observation of the dipsogenic response. For all in vivo and gene expression experiments, MTII (Phoenix Pharmaceuticals) was reconstituted in aCSF to a concentration of 500 μM (500 pM/μL), which allowed for delivery of 1 nmol of MTII in 2 μL, aCSF was used as the vehicle control.
+ Open protocol
+ Expand
6

Neuronal Cell Culture and Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DMEM medium, Neurobasal A medium, F-12 medium, Fetal Bovine Serum (FBS), HBSS, D-PBS, Penicillin/Streptomycin, B-27, Collagenase II, Dispase II, Trypsin, Alexa Fluor® 647 conjugated anti-rabbit antibody, and DiSBAC2(3) were purchased from Life Technologies (Carlsbad, CA, USA). DNAse 1, 30% BSA, Cytosine β-d-arabinofuranoside hydrochloride (ARA-c), 5-Fluoro-2′-deoxyuridine 5′-monophosphate sodium salt (FdU) solution (FdU), poly-d-Lysine, DAPI, and 10% neutral buffered formalin solution were purchased from Sigma-Aldrich (Saint Louis, MO, USA). Angiotensin II was purchased from Tocris (Bristol, UK). C21 (MW = 475.2) and EMA401 (MW = 507.2) were synthesized by AGV discovery (Clapiers, France), purified by HPLC (>95%), and characterized by 1H NMR (Figures S3 and S4) and mass spectrometry. Anti-rabbit β3-Tubulin (D71G9) XP® (anti-Tuj1) was purchased from Cell Signaling Technologies® (Danvers, MA, USA). Micro-titer plate (384-well), µClear®, was purchased from Greiner Bio-One SAS (Les Ulis, France). Purified mycolactone was obtained and quantified as described in a previous study [9 (link)], and re-suspended in DMSO at 5 mg/mL and stored at −20 °C as aliquots in amber glass tubes.
+ Open protocol
+ Expand
7

Angiotensin-II and Forskolin Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
H295R cells were transferred to 12 wells dishes in groups of 600,000 cells per well, and maintained at the conditions described. After 24h passage, DMEM/Eagle’s F12 medium supplemented with 0.1% CCS and, after 48h, DMEM/Eagle’s F12 media containing angiotensin-II (Tocris, Bristol, United Kingdom) (10nM), and forskolin (Tocris) (10 μM) were added to different groups of cells, each group comprising 3 wells. A basal group, to which no drug was added, was used a control. RNA was extracted at 3, 6, 12, and 24h time points (RNeasy Mini Kit, QIAGEN, Hilden, Germany). All the cell experiments were independently conducted in triplicate, with cells raised at different times.
+ Open protocol
+ Expand
8

Olanzapine and Angiotensin II Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Olanzapine (PubChem CID: 4585) was a generous gift of Neuland Laboratories Ltd (Hyderabad, India). Angiotensin II (PubChem CID: 172198) and rimonabant (RIM; PubChem CID: 104850) were purchased from Tocris Bioscience (Minneapolis, Minnesota). Angiotensin II was used at the end of the experiment to verify that the intracerebroventricular (ICV) cannulas were placed correctly by performing a water drinking test.
+ Open protocol
+ Expand
9

I-S1 and T-Alb Biodistribution in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
In anesthetized mice, the left jugular vein was exposed for an iv injection of 0.1 mL BSA-LR containing 3×105 cpm of I-S1 (RayBiotech) and 6×105 cpm of T-Alb. For some mice, the injection contained 1 μg/mouse of unlabeled S1 (AMSBIO), mouse acyl ghrelin (CBio, Menlo Park, CA), angiotensin II (Tocris, Bristol, UK), or human ACE2 (R&D, Minneapolis, MN). Ten min after iv injection, whole blood was obtained from the carotid artery and centrifuged after clotting. The whole brain, olfactory bulb, kidney, spleen, and portions of the liver and lung removed. The levels of radioactivity in the arterial serum and the tissues were determined and the results expressed as the percent of the injected I-S1 per mL for serum and delta tissue/serum ratios (μL/g) for the tissues.
+ Open protocol
+ Expand
10

Exendin-4, GLP-1, and Angiotensin II Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exendin-4 (Ex4), GLP-1 (7–36) and angiotensin II, were purchased from Tocris (Bristol, UK) dissolved in aCSF (vehicle for all central injections) and stored as aliquots in -20°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!